Teladoc is expected to report a net loss of $3.18/share in 2021, resulting in 41% growth from -$5.36/share in the fiscal year 2020. The consensus EPS estimate for the fiscal year 2025 is $2.57/share, or 181% growth from 2021 expectations.
Similarly, Will Teladoc ever make money?
Teladoc has never turned a profit — at least not using generally accepted accounting principles (GAAP). Yet hypergrowth fueled by the pandemic and a few acquisitions have pushed revenue up nearly three-fold since the end of 2019.
Why is Teladoc stock down? Teladoc stock fell in after-hours trading Tuesday after the telehealth giant posted fourth-quarter earnings, despite results exceeding Wall Street’s expectations on profit and revenue.
Thereof, Why is Teladoc stock going down?
The stock price of Teladoc (NASDAQ:TDOC), a telemedicine and virtual healthcare company, has seen a fall of 20% over the last month, while it is down more than 70% over the last one year. The market is trying to look beyond Covid-19, as therapeutic options for Covid-19 improve and as the virus potentially gets milder.
Is Teladoc undervalued?
Is Teladoc Stock Undervalued? TDOC is not profitable yet, thus we can’t value the company on a price-to-earnings basis. We can look at other metrics to gauge whether shares are expensive, however.
Is Teladoc stock undervalued?
Is Teladoc Stock Undervalued? TDOC is not profitable yet, thus we can’t value the company on a price-to-earnings basis. We can look at other metrics to gauge whether shares are expensive, however.
Why has Teladoc stock gone down?
The stock price of Teladoc (NASDAQ:TDOC), a telemedicine and virtual healthcare company, has seen a fall of 20% over the last month, while it is down more than 70% over the last one year. The market is trying to look beyond Covid-19, as therapeutic options for Covid-19 improve and as the virus potentially gets milder.
Who are Teladoc competitors?
Teladoc Health’s top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare. Teladoc Health is a telehealth company that uses telephone and video conferencing technology to provide on-demand remote medical care via mobile devices, the internet, and video.
Will Teladoc stock recover?
Teladoc stock is set for a big comeback, says Goldman Sachs.
Teladoc (ticker: TDOC) stock was battered in 2021. Though memberships boomed as the pandemic unfolded in 2020, sending the stock up nearly 139% that year, such gains created a high bar that Teladoc struggled to clear the following year.
What is the target price for Teladoc?
The 26 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 95.00, with a high estimate of 161.00 and a low estimate of 60.00. The median estimate represents a +38.06% increase from the last price of 68.81.
How low can teladoc go?
Teladoc Health Inc (NYSE:TDOC)
The 25 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 94.00, with a high estimate of 215.00 and a low estimate of 60.00. The median estimate represents a +27.47% increase from the last price of 73.74.
How does teladoc make money?
How does Teladoc Make Money? Teladoc’s major revenue source is from the subscription-based model. Patients pay annual or monthly fees for consultation. The subscription-based plan starts from $49, they also sell services to clients on behalf of their employees.
Will teladoc rebound?
They’re trading at little more than four times sales. This is their lowest by that measure since 2016. It’s impossible to predict when Teladoc will rebound.
Is TDOC oversold?
This is conveyed through the Relative Strength Index (RSI). TDOC stock’s RSI of 29.9 indicates it’s oversold, as it trades below the 30 benchmark.
Who is Teladoc biggest competitor?
1. Amwell. Amwell (NYSE: AMWL) formerly known as American Well, is a telemedicine company founded in 2006 and went public in 2020. It is currently the biggest competitor to Teladoc in the telehealth space and has experienced significant growth in recent times.
How does Teladoc make money?
How does Teladoc Make Money? Teladoc’s major revenue source is from the subscription-based model. Patients pay annual or monthly fees for consultation. The subscription-based plan starts from $49, they also sell services to clients on behalf of their employees.
What company owns Teladoc?
Top 10 Owners of Teladoc Health Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| ARK Investment Management LLC | 11.80% | 18,922,198 |
| The Vanguard Group, Inc. | 8.00% | 12,824,319 |
| Baillie Gifford & Co. | 6.78% | 10,877,063 |
| Nikko Asset Management Co., Ltd. | 5.70% | 9,140,808 |
How much cash does Teladoc have?
Compare TDOC With Other Stocks
| Teladoc Health Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2020 | $787 |
| 2019 | $517 |
| 2018 | $479 |
| 2017 | $122 |
Who will acquire teladoc?
During a special meeting of shareholders Thursday, Teladoc Health’s shareholders approved the deal with more than 99% in approval. Livongo shareholders also approved the acquisition with more than 99% of votes in approval, Teladoc said in a Thursday release.
What is the target price for AMD?
Research & Ratings | AMD | Barron’s.
…
Stock Price Target.
| High | $200.00 |
|---|---|
| Low | $100.00 |
| Average | $148.19 |
| Current Price | $97.74 |
What is the target price for Amazon stock?
Stock Price Target AMZN
| High | $ 5,000.00 |
|---|---|
| Median | $ 4,100.00 |
| Low | $ 2,800.00 |
| Average | $ 4,107.47 |
| Current Price | $ 3,110.82 |
Join TheMoney.co community and don’t forget to share this post !
